HSPG2 and neoplasm: Overall 94.9% of patients with a positive PLC had a T3/T4 tumor and 100% of the patients with a positive PLC had a N-positive tumor (P < 0.001); in 76.9% of patients with a positive PLC, the tumor grade was low (P = 0.001).